• Return to Headlines

Shares of Atara Biotherape Has Fallen Below Previous 52-Week Low

By Amy Schwartz

Atara Biotherape (NASDAQ:ATRA) traded today at a new 52-week low of $22.54. This new low was reached on below average trading volume as 125,000 shares traded hands, while the average 30-day volume is approximately 572,000 shares.

There is potential upside of 108.5% for shares of Atara Biotherape based on a current price of $22.54 and an average consensus analyst price target of $47.00. The stock should find initial resistance at its 50-day moving average (MA) of $34.15 and further resistance at its 200-day MA of $36.71.

In the past 52 weeks, Atara Biotherape share prices have been bracketed by a current low of $22.54 and a high of $54.45 and are now at $22.54. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.4% while the 200-day MA has slid 0.5%.

Atara Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on developing therapies for patients with severe and life-threatening diseases.

SmarTrend is tracking the current trend status for Atara Biotherape and will alert subscribers who have ATRA in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows atara biotherape

Ticker(s): ATRA